Presentation TCT 2013

Bioresorbable Vascular Scaffolds and Drug-Eluting Balloons: Which Subsets Meaningfully Benefit Beyond Metallic DES?

Presenter: Patrick Serruys

October 31, 2013

REGISTER for free or LOG IN to view this content

Bioresorbable Vascular Scaffolds and Drug-Eluting Balloons: Which Subsets Meaningfully Benefit Beyond Metallic DES?

DES/BRS/DCB

Presentation

TCT 2013

Up Next

Presentation TCT 2013

IA Treatment: Where Do We Stand Now? Including Analysis of Recent Negative Trials

Presenter: Philip Meyers

October 31, 2013

More slides +

Presentation TCT 2013

BVS Follow-up Using Multiple Imaging Modalities: Research Implications vs. Clinical Utility

Presenter: Yoshinobu Onuma

October 31, 2013

Presentation TCT 2013

Cangrelor Will Be the Answer for Most in the Acute Setting!

Presenter: Robert Harrington

October 31, 2013

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.